BrainsWay Ltd.: financial analysis
Ratios worked out from 8 fiscal years of BrainsWay Ltd.'s statements, compared with 1,209 companies in Healthcare.
BrainsWay Ltd. scorecard#
Passes 8 of the 12 checks that could be worked out: strongest in growth (5 of 6), weakest in profitability (3 of 5). Fiscal year 2024; market cap of Aug 1, 2026.
Valuationnot known
- –P/E below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to book below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to sales below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Free cash flow yield above 5%The market cap dates from 2026-08-01, more than 60 days ago.
- –Earnings yield above the 10-year Treasury yieldThe market cap dates from 2026-08-01, more than 60 days ago.
- –The price assumes slower growth than the last three years'The market cap dates from 2026-08-01, more than 60 days ago.
Growth5 of 6
- ✓Revenue grew in the newest year29.1%Revenue up 29.1% in fiscal 2024.
- ✓Revenue up more than 5% a year over three years11.4%11.4% a year over the three years to fiscal 2024.
- ✓Faster growth over three years than its peers' median11.4%11.4% a year against Healthcare's median of 8.5% (549 companies).
- ✓Earnings per share grew in the newest year0.05 vs -0.13Diluted EPS 0.05 in fiscal 2024 against -0.13 the year before (report's currency).
- ✓Net income higher than five years earlier$3 M$3 M in fiscal 2024 against -$10 M in 2019.
- ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2024.
Profitability3 of 5
- ✓Profitable in the newest year$3 MNet income $3 M in fiscal 2024.
- ✗Profitable in each of the last five years1 of 5Profitable in 1 of the five years to fiscal 2024.
- ✓Operating margin above its peers' median3.4%3.4% against Healthcare's median of -7.7% (674 companies).
- ✗Return on equity above 15%5.6%5.6% in fiscal 2024.
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier3.4%3.4% in fiscal 2024 against -16.9% in 2021.
Financial health0 of 1
- –Short-term assets cover short-term liabilitiesCurrent assets and liabilities are not on file.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years2 of 3Positive in 2 of the three years to fiscal 2024.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returnsnot known
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- –Share count up no more than 2% in a yearShare counts of two years are not on file.
- –Dividends and buybacks above 3% of the market valueThe market cap dates from 2026-08-01, more than 60 days ago.
- –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.
Worked out from the statements as filed (sec), the medians of Healthcare, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Piotroski F-score
Nine yes/no tests of whether the company's finances improved in the year. One point each.
- Made a profityes
- Operations brought in cashyes
- Return on assets roseyes
- Cash from operations exceeds profityes
- Long-term debt fell against assetsnot on file
- Current ratio rosenot on file
- No new shares issuedno
- Gross margin roseyes
- Asset turnover roseno
Where the return on equity comes from
The DuPont split: margin, times how hard the assets work, times how much of them is financed by others.
Profitability#
| Fiscal year | Trend | 2024 | 2023 | 2022 | 2021 | 2020 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 74.6% | 73.9% | 73.8% | 77.8% | 77.1% | 58.4% | 74% | |
| Operating margin | 3.4% | -15.6% | -46.7% | -16.9% | -21.9% | -7.7% | 63% | |
| Net margin | 7.1% | -13.2% | -49.1% | -21.8% | -24.4% | -8.1% | 74% | |
| Return on equity | 5.6% | -9.7% | -26.0% | -16.8% | -24.5% | -36.9% | 77% | |
| Return on assets | 3.7% | -6.6% | -19.0% | -11.8% | -14.8% | -29.1% | 81% |
Growth#
| Fiscal year | Trend | 2024 | 2023 | 2022 | 2021 | 2020 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | 29.1% | 16.9% | -8.4% | 34.5% | -4.5% | 10.2% | 76% | |
| Revenue growth, 3 years a year | 11.4% | 12.9% | 5.6% | 21.8% | 25.6% | 8.5% | 57% | |
| Revenue growth, 5 years a year | 12.2% | 14.2% | 19.5% | — | — | 11.5% | 53% |
Financial strength#
| Fiscal year | Trend | 2024 | 2023 | 2022 | 2021 | 2020 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Debt to equity | — | — | — | — | — | 0.45× | — | |
| Net debt | — | — | — | — | — | $7 M | — | |
| Interest cover | — | — | — | — | — | -6.90× | — | |
| Current ratio | — | — | — | — | — | 3.18× | — | |
| Equity share of assets | 66.1% | 66.0% | 70.4% | 75.7% | 57.7% | 56.0% | 59% |
Cash#
| Fiscal year | Trend | 2024 | 2023 | 2022 | 2021 | 2020 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Free cash flow | — | — | — | $-1 M | $-4 M | $-11 M | — | |
| Free cash flow margin | — | — | — | -4.6% | -17.7% | -1.3% | — | |
| Cash conversion | 352.7% | — | — | — | — | 147.6% | 88% | |
| Capital spending share of revenue | — | — | — | 7.6% | 11.2% | 2.3% | — |
Efficiency#
| Fiscal year | Trend | 2024 | 2023 | 2022 | 2021 | 2020 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Asset turnover | 0.52× | 0.50× | 0.39× | 0.54× | 0.61× | 0.53× | 49% |
How each figure is worked out#
- Gross margin
- Gross profit as a share of revenue.
- Operating margin
- Operating income as a share of revenue.
- Net margin
- Net income as a share of revenue.
- Return on equity
- Net income as a share of shareholders' equity (the average of the start and the end of the year). Not given when equity is negative.
- Return on assets
- Net income as a share of total assets (average of the year).
- Revenue growth
- Revenue against the year before.
- Revenue growth, 3 years a year
- The yearly rate that takes revenue of three years earlier to this year's.
- Revenue growth, 5 years a year
- The yearly rate that takes revenue of five years earlier to this year's.
- Debt to equity
- Total debt divided by shareholders' equity. Not given when equity is negative.
- Net debt
- Total debt less cash. Negative means more cash than debt.
- Interest cover
- Operating income divided by the interest paid on debt.
- Current ratio
- Assets due within a year divided by liabilities due within a year.
- Equity share of assets
- Shareholders' equity as a share of total assets.
- Free cash flow
- Cash from operations less capital spending.
- Free cash flow margin
- Free cash flow as a share of revenue.
- Cash conversion
- Cash from operations as a share of net income. Only when the year was profitable.
- Capital spending share of revenue
- Capital spending as a share of revenue.
- Asset turnover
- Revenue divided by total assets (average of the year).
Source: BrainsWay Ltd.'s statements: annual reports filed with the SEC. Arithmetic on reported figures, in US dollars; nothing is estimated. A figure is blank when a line it needs is not in the statements on file, and left out when the result cannot be right (a margin from next to no revenue). "Ahead of" is the share of the 1,209 companies in Healthcare that BrainsWay Ltd. is better than on that figure, using each company's newest fiscal year; yields use today's market value. Medians for every industry · Back to BrainsWay Ltd.